01 | 2008
VTT develops technologies for drug discovery
Significant progress has been achieved in recent years in Finland in the medical biotechnology and molecular medicine fields. Active efforts to commercialise these fields were started over ten years ago, and these efforts are now beginning to yield positive results after some initial difficulties.
VTT, Helsinki University of Technology and UPM to establish an internationally unique Finnish Centre for Nanocellulosic Technologies
Science, research and industrial partners are turning nanotechnology into evolving product platform
The internationally unique Finnish Centre for Nanocellulosic Technologies aims to create new applications for cellulose as a raw material, substance and end product. Cellulose-based nanofibres can be used to alter the structure of the material and create products that better correspond to future market needs.
New technology offers a considerable savings potential for healthcare
VTT and A*STAR Agency for Science, Technology and Research from Singapore have developed remote healthcare services that allow patients to be treated globally independent of time and location and irrespective of the solutions provided by hardware and data system suppliers. In Finland, the first trial services for treating cardiac patients and patients suffering from chronic illnesses have been promising.
VTT is an impartial expert organisation. Its objective is to develop new technologies, create new innovations and value added thus increasing customer's competencies. With its know how VTT produces research, development, testing and information services to public sector and companies as well as international organisations.